Literature DB >> 19369345

Kinetic dependence of paramyxovirus entry inhibition.

Matteo Porotto1, Christine C Yokoyama, Gianmarco Orefice, Han-Sung Kim, Mohamed Aljofan, Bruce A Mungall, Anne Moscona.   

Abstract

Peptides derived from conserved heptad repeat (HR) regions of paramyxovirus fusion (F) proteins inhibit viral fusion by interfering with the formation of the fusogenic six-helix bundle structure. Peptide efficacy is affected by the strength of the peptide association with the target virus's complementary HR region. Here, we show that a second basis for peptide efficacy lies in the kinetics of F activation by the homotypic attachment protein: efficient F activation by the attachment protein shortens the period during which antiviral molecules targeting intermediate states of F may act, thereby modulating the effectiveness of inhibitory peptides. These results highlight new issues to be considered in developing strategies for fusion inhibitors.

Mesh:

Substances:

Year:  2009        PMID: 19369345      PMCID: PMC2698554          DOI: 10.1128/JVI.00416-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

Authors:  M Lu; S C Blacklow; P S Kim
Journal:  Nat Struct Biol       Date:  1995-12

2.  Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling.

Authors:  J K Young; R P Hicks; G E Wright; T G Morrison
Journal:  Virology       Date:  1997-11-24       Impact factor: 3.616

3.  Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.

Authors:  Q Yao; R W Compans
Journal:  Virology       Date:  1996-09-01       Impact factor: 3.616

4.  Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein.

Authors:  T F Wild; R Buckland
Journal:  J Gen Virol       Date:  1997-01       Impact factor: 3.891

5.  Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.

Authors:  D M Lambert; S Barney; A L Lambert; K Guthrie; R Medinas; D E Davis; T Bucy; J Erickson; G Merutka; S R Petteway
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

6.  Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.

Authors:  C T Wild; D C Shugars; T K Greenwell; C B McDanal; T J Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

7.  Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion.

Authors:  A Moscona; R W Peluso
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

8.  A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

Authors:  C Wild; T Oas; C McDanal; D Bolognesi; T Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.

Authors:  John V Williams; Paul A Harris; Sharon J Tollefson; Lisa L Halburnt-Rush; Joyce M Pingsterhaus; Kathryn M Edwards; Peter F Wright; James E Crowe
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

10.  A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses.

Authors:  D Rapaport; M Ovadia; Y Shai
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

View more
  20 in total

Review 1.  Modes of paramyxovirus fusion: a Henipavirus perspective.

Authors:  Benhur Lee; Zeynep Akyol Ataman
Journal:  Trends Microbiol       Date:  2011-04-20       Impact factor: 17.079

2.  Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery.

Authors:  Shohreh F Farzan; Laura M Palermo; Christine C Yokoyama; Gianmarco Orefice; Micaela Fornabaio; Aurijit Sarkar; Glen E Kellogg; Olga Greengard; Matteo Porotto; Anne Moscona
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

3.  The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion.

Authors:  Matteo Porotto; Zuhair Salah; Ilaria DeVito; Aparna Talekar; Samantha G Palmer; Rui Xu; Ian A Wilson; Anne Moscona
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

4.  Viral entry inhibitors targeted to the membrane site of action.

Authors:  Matteo Porotto; Christine C Yokoyama; Laura M Palermo; Bruce Mungall; Mohamad Aljofan; Riccardo Cortese; Antonello Pessi; Anne Moscona
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

5.  Infection of primary neurons mediated by nipah virus envelope proteins: role of host target cells in antiviral action.

Authors:  Aparna Talekar; Antonello Pessi; Matteo Porotto
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

6.  Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides.

Authors:  C Mathieu; D Huey; E Jurgens; J C Welsch; I DeVito; A Talekar; B Horvat; S Niewiesk; A Moscona; M Porotto
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

7.  Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry.

Authors:  Matteo Porotto; Barry Rockx; Christine C Yokoyama; Aparna Talekar; Ilaria Devito; Laura M Palermo; Jie Liu; Riccardo Cortese; Min Lu; Heinz Feldmann; Antonello Pessi; Anne Moscona
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

8.  Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity.

Authors:  Laura M Palermo; Matteo Porotto; Christine C Yokoyama; Samantha G Palmer; Bruce A Mungall; Olga Greengard; Stefan Niewiesk; Anne Moscona
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

9.  Fatal measles virus infection prevented by brain-penetrant fusion inhibitors.

Authors:  Jeremy C Welsch; Aparna Talekar; Cyrille Mathieu; Antonello Pessi; Anne Moscona; Branka Horvat; Matteo Porotto
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

10.  Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection.

Authors:  Samantha G Palmer; Ilaria DeVito; Stephen G Jenkins; Stefan Niewiesk; Matteo Porotto; Anne Moscona
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.